Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant EOS chemotherapy for locally advanced gastric cancer
ChiCTR-ONC-14004666Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epirubicin, cisplatin and tegafur in gastric cancer (GC), sponsored by West China Hospital of Sichuan University. Primary endpoint: Objective response. Started Sep 2014; status: recruiting.
02
Drugs
epirubicincisplatintegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-ONC-14004666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-14004666.